Ipamorelin: 100 to 300 mcg per injection, 1 to 3 times daily
If your primary concern involves gastritis, leaky gut, intestinal inflammation, or other digestive issues, oral BPC-157 makes theoretical sense and receives the most favorable user reports
Baig MH, Ahmad K, Moon JS, Park SY, Ho Lim J, Chun HJ, et al
While this effect appears to be related to the magnitude and rapidity of glucose lowering rather than a direct effect of the medication itself, patients with a history of diabetic retinopathy should undergo careful ophthalmologic evaluation before and during treatment, and the potential risks should be weighed against the expected benefits of improved glycemic control
When downtime is reduced, training frequency and output can be maintained more consistently, supporting progressive overload and strength adaptation
Extremes in energy balance are considered harmful